Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases
| Ano de defesa: | 2020 |
|---|---|
| Autor(a) principal: | |
| Orientador(a): | |
| Banca de defesa: | |
| Tipo de documento: | Dissertação |
| Tipo de acesso: | Acesso aberto |
| Idioma: | por |
| Instituição de defesa: |
Não Informado pela instituição
|
| Programa de Pós-Graduação: |
Não Informado pela instituição
|
| Departamento: |
Não Informado pela instituição
|
| País: |
Não Informado pela instituição
|
| Palavras-chave em Português: | |
| Link de acesso: | http://www.repositorio.ufc.br/handle/riufc/55888 |
Resumo: | The apremilast, marketed as OTZELA®, is a oral drug, used in psoriases and psoriatic arthritis psoriatic, acting as a anti-inflammatory. Is a recent drug, which was approved for FDA (Food Drug Administration) in 2014. The drug referred have a only stereogenic center and is commercialized in enantiomerically pure form, since what the (S)-enantiomer is more active which the (R)-enantiomer. In this work we describe the preliminary results referred the chemoenzymatic synthesis of apremilast intermediates in lipases presence, being the key-step, the obtaining of amine (S-2)-1-(3-ethoxy-4-methoxyphenyl)-1-methylsulfonyl-2-ethylamine, (S)-36. That intermediate can be obtained through kinetic resolution of amine rac-36, via carbamation reaction using lipases. The amine rac-36 was prepared, as 70% yield, via two sequential steps one-pot, which consisted in 3-ethoxy-4-methoxybenzonitrile, 38, reaction with (methylsulfonyl)methanide (formed carbanion among the dimethylsulfone and n-butyl-lithium), with obtaining of the enamine 1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethenamine 39, treatment followed with NaBH4, in glacial acetic acid. The 1-(3-ethoxy-4-methoxyfenyl)-2-(mehtylsulfonyl)ethyl)alyl carbamate, rac-49, was prepared starting of amine rac-34 via carbamation reaction with allyl chloroformate, in triethylamine presence, 89% yield. Both, the amine rac-34 and the carbamate rac-49 corresponding was analyzed by CLAE, using a chiral column, and ideal conditions for the enantiomers separation. The first approach to be studied was the lipase behavior in several solvents in 40 ºC for 72 h for kinetic resolution of amine rac-36, via carbamation reaction. Highlighted the solvents which show low value of dielectric constant: THF, TBME, hexane, cyclohexane and toluene, since which the best result was obtained in hexane, in CAL-B presence, as 14% conversion and >200 enantioselectivity (E). Also of CAL-B, the Candida rugosa lipase and CAL-A are promising in kinetic resolution of rac-36. In parallel, the commercial anhydride 3- nitrophthalic anhydride 50, was effectively transforming in 3-aminophthalic, 51, qualitative yield. The latter was subjected to an acetylation reaction to obtain 3-acetylaminophthalic anhydride 37, one of apremilast's intermediates, but with a yield of only 25%. |
| id |
UFC-7_0beee59f6c6ef7c9535b959bea9d0fed |
|---|---|
| oai_identifier_str |
oai:repositorio.ufc.br:riufc/55888 |
| network_acronym_str |
UFC-7 |
| network_name_str |
Repositório Institucional da Universidade Federal do Ceará (UFC) |
| repository_id_str |
|
| spelling |
Oliveira, Artur Ramon ToméSilva, Marcos Reinaldo daMattos, Marcos Carlos de2020-12-31T15:55:25Z2020-12-31T15:55:25Z2020OLIVEIRA, Artur Ramon Tomé. Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases. 2020. 82 f. Dissertação (Mestrado em Química) - Centro de Ciências, Universidade Federal do Ceará, Fortaleza, 2020.http://www.repositorio.ufc.br/handle/riufc/55888The apremilast, marketed as OTZELA®, is a oral drug, used in psoriases and psoriatic arthritis psoriatic, acting as a anti-inflammatory. Is a recent drug, which was approved for FDA (Food Drug Administration) in 2014. The drug referred have a only stereogenic center and is commercialized in enantiomerically pure form, since what the (S)-enantiomer is more active which the (R)-enantiomer. In this work we describe the preliminary results referred the chemoenzymatic synthesis of apremilast intermediates in lipases presence, being the key-step, the obtaining of amine (S-2)-1-(3-ethoxy-4-methoxyphenyl)-1-methylsulfonyl-2-ethylamine, (S)-36. That intermediate can be obtained through kinetic resolution of amine rac-36, via carbamation reaction using lipases. The amine rac-36 was prepared, as 70% yield, via two sequential steps one-pot, which consisted in 3-ethoxy-4-methoxybenzonitrile, 38, reaction with (methylsulfonyl)methanide (formed carbanion among the dimethylsulfone and n-butyl-lithium), with obtaining of the enamine 1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethenamine 39, treatment followed with NaBH4, in glacial acetic acid. The 1-(3-ethoxy-4-methoxyfenyl)-2-(mehtylsulfonyl)ethyl)alyl carbamate, rac-49, was prepared starting of amine rac-34 via carbamation reaction with allyl chloroformate, in triethylamine presence, 89% yield. Both, the amine rac-34 and the carbamate rac-49 corresponding was analyzed by CLAE, using a chiral column, and ideal conditions for the enantiomers separation. The first approach to be studied was the lipase behavior in several solvents in 40 ºC for 72 h for kinetic resolution of amine rac-36, via carbamation reaction. Highlighted the solvents which show low value of dielectric constant: THF, TBME, hexane, cyclohexane and toluene, since which the best result was obtained in hexane, in CAL-B presence, as 14% conversion and >200 enantioselectivity (E). Also of CAL-B, the Candida rugosa lipase and CAL-A are promising in kinetic resolution of rac-36. In parallel, the commercial anhydride 3- nitrophthalic anhydride 50, was effectively transforming in 3-aminophthalic, 51, qualitative yield. The latter was subjected to an acetylation reaction to obtain 3-acetylaminophthalic anhydride 37, one of apremilast's intermediates, but with a yield of only 25%.O apremilast, comercializado como OTZELA®, é um fármaco oral, utilizado no tratamento da psoríase e da artrite psoriática, atuando como um anti-inflamatório. É um fármaco recente, que foi aprovado pela FDA (Food Drug Administration) em 2014. O referido fármaco possui apenas um centro estereogênico e é comercializado na forma enantiomericamente pura, já que o (S)-enantiômero é mais ativo que o (R)-enantiômero. Neste trabalho descrevemos os resultados preliminares referentes à síntese quimioenzimática de intermediários do apremilast na presença de lipases, sendo a etapa chave, a obtenção da amina (S-2)-1-(3-etoxi-4-metoxifenil)-1-metilssulfonil-2-etilamina, (S)-36. Esse intermediário pode ser obtido através da resolução cinética da amina rac-36, via reação de carbamatação, catalisada por lipases. A amina rac-36 foi preparada, com 70% de rendimento, via duas etapas sequenciais one-pot, que consistiu na reação da 3-etoxi-4-metoxibenzonitrila 38 com o (metilssulfonil)metanídeo (carbânion formado entre a dimetilssulfona e n-butil-lítio), com a obtenção da enamina 1-(3-etoxi-4-metoxifenil)-2-(metilssulfonil)etenamina 39, seguido de tratamento com NaBH4, em ácido acético glacial. O carbamato de 1-(3-etoxi-4-metoxifenil)-2-(metilssulfonil)etil)alila rac-49 foi preparado a partir da amina rac-34 via reação de carbamatação com cloroformato de alila, na presença de trietilamina, com rendimento de 89%. Ambos, a amina rac-34 e o correspondente carbamato rac-49 foram analisados por CLAE, utilizando coluna quiral, e condições adequadas para a separação de seus correspondentes enantiômeros. A primeira abordagem a ser estudada foi o comportamento de lipases em diferentes solventes a 40 ºC por 72 h na resolução cinética da amina rac-36, via reação de carbamatação. Destacaram-se os solventes que apresentaram baixos valores de constante dielétrica: THF, TBME, hexano, cicloexano e tolueno, sendo que o melhor resultado foi obtido em hexano, na presença de CAL-B, com conversão de 14% e enantiosseletividade (E) >200. Além da CAL-B, a lipase de Candida rugosa e CAL-A mostram-se promissoras na resolução cinética de rac-36. Em paralelo, o anidrido comercial 3-nitroftálico 50 foi eficientemente transformado no anidrido-3-aminoftálico 51, em rendimento quantitativo. Este último, foi submetido a uma reação de acetilação para a obtenção do anidrido 3-acetilaminoftálico 37, um dos intermediários do apremilast, porém com rendimento de apenas 25%.CarbamataçãoLipasesApremilastResolução cinética enzimáticaSíntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipasesChemioenzymatic synthesis of apremilast via carbamatation intermediates, using lipasesinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisporreponame:Repositório Institucional da Universidade Federal do Ceará (UFC)instname:Universidade Federal do Ceará (UFC)instacron:UFCinfo:eu-repo/semantics/openAccessLICENSElicense.txtlicense.txttext/plain; charset=utf-81748http://repositorio.ufc.br/bitstream/riufc/55888/4/license.txt8a4605be74aa9ea9d79846c1fba20a33MD54ORIGINAL2020_dis_artoliveira.pdf2020_dis_artoliveira.pdfapplication/pdf2505180http://repositorio.ufc.br/bitstream/riufc/55888/3/2020_dis_artoliveira.pdfbe274a18cb8508ec24ce528e73b96166MD53riufc/558882020-12-31 12:55:25.544oai:repositorio.ufc.br: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Repositório InstitucionalPUBhttp://www.repositorio.ufc.br/ri-oai/requestbu@ufc.br || repositorio@ufc.bropendoar:2020-12-31T15:55:25Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC)false |
| dc.title.pt_BR.fl_str_mv |
Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases |
| dc.title.en.pt_BR.fl_str_mv |
Chemioenzymatic synthesis of apremilast via carbamatation intermediates, using lipases |
| title |
Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases |
| spellingShingle |
Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases Oliveira, Artur Ramon Tomé Carbamatação Lipases Apremilast Resolução cinética enzimática |
| title_short |
Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases |
| title_full |
Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases |
| title_fullStr |
Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases |
| title_full_unstemmed |
Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases |
| title_sort |
Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases |
| author |
Oliveira, Artur Ramon Tomé |
| author_facet |
Oliveira, Artur Ramon Tomé |
| author_role |
author |
| dc.contributor.co-advisor.none.fl_str_mv |
Silva, Marcos Reinaldo da |
| dc.contributor.author.fl_str_mv |
Oliveira, Artur Ramon Tomé |
| dc.contributor.advisor1.fl_str_mv |
Mattos, Marcos Carlos de |
| contributor_str_mv |
Mattos, Marcos Carlos de |
| dc.subject.por.fl_str_mv |
Carbamatação Lipases Apremilast Resolução cinética enzimática |
| topic |
Carbamatação Lipases Apremilast Resolução cinética enzimática |
| description |
The apremilast, marketed as OTZELA®, is a oral drug, used in psoriases and psoriatic arthritis psoriatic, acting as a anti-inflammatory. Is a recent drug, which was approved for FDA (Food Drug Administration) in 2014. The drug referred have a only stereogenic center and is commercialized in enantiomerically pure form, since what the (S)-enantiomer is more active which the (R)-enantiomer. In this work we describe the preliminary results referred the chemoenzymatic synthesis of apremilast intermediates in lipases presence, being the key-step, the obtaining of amine (S-2)-1-(3-ethoxy-4-methoxyphenyl)-1-methylsulfonyl-2-ethylamine, (S)-36. That intermediate can be obtained through kinetic resolution of amine rac-36, via carbamation reaction using lipases. The amine rac-36 was prepared, as 70% yield, via two sequential steps one-pot, which consisted in 3-ethoxy-4-methoxybenzonitrile, 38, reaction with (methylsulfonyl)methanide (formed carbanion among the dimethylsulfone and n-butyl-lithium), with obtaining of the enamine 1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethenamine 39, treatment followed with NaBH4, in glacial acetic acid. The 1-(3-ethoxy-4-methoxyfenyl)-2-(mehtylsulfonyl)ethyl)alyl carbamate, rac-49, was prepared starting of amine rac-34 via carbamation reaction with allyl chloroformate, in triethylamine presence, 89% yield. Both, the amine rac-34 and the carbamate rac-49 corresponding was analyzed by CLAE, using a chiral column, and ideal conditions for the enantiomers separation. The first approach to be studied was the lipase behavior in several solvents in 40 ºC for 72 h for kinetic resolution of amine rac-36, via carbamation reaction. Highlighted the solvents which show low value of dielectric constant: THF, TBME, hexane, cyclohexane and toluene, since which the best result was obtained in hexane, in CAL-B presence, as 14% conversion and >200 enantioselectivity (E). Also of CAL-B, the Candida rugosa lipase and CAL-A are promising in kinetic resolution of rac-36. In parallel, the commercial anhydride 3- nitrophthalic anhydride 50, was effectively transforming in 3-aminophthalic, 51, qualitative yield. The latter was subjected to an acetylation reaction to obtain 3-acetylaminophthalic anhydride 37, one of apremilast's intermediates, but with a yield of only 25%. |
| publishDate |
2020 |
| dc.date.accessioned.fl_str_mv |
2020-12-31T15:55:25Z |
| dc.date.available.fl_str_mv |
2020-12-31T15:55:25Z |
| dc.date.issued.fl_str_mv |
2020 |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
| format |
masterThesis |
| status_str |
publishedVersion |
| dc.identifier.citation.fl_str_mv |
OLIVEIRA, Artur Ramon Tomé. Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases. 2020. 82 f. Dissertação (Mestrado em Química) - Centro de Ciências, Universidade Federal do Ceará, Fortaleza, 2020. |
| dc.identifier.uri.fl_str_mv |
http://www.repositorio.ufc.br/handle/riufc/55888 |
| identifier_str_mv |
OLIVEIRA, Artur Ramon Tomé. Síntese quimioenzimática dos intermediários do apremilast via carbamatação, utilizando lipases. 2020. 82 f. Dissertação (Mestrado em Química) - Centro de Ciências, Universidade Federal do Ceará, Fortaleza, 2020. |
| url |
http://www.repositorio.ufc.br/handle/riufc/55888 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da Universidade Federal do Ceará (UFC) instname:Universidade Federal do Ceará (UFC) instacron:UFC |
| instname_str |
Universidade Federal do Ceará (UFC) |
| instacron_str |
UFC |
| institution |
UFC |
| reponame_str |
Repositório Institucional da Universidade Federal do Ceará (UFC) |
| collection |
Repositório Institucional da Universidade Federal do Ceará (UFC) |
| bitstream.url.fl_str_mv |
http://repositorio.ufc.br/bitstream/riufc/55888/4/license.txt http://repositorio.ufc.br/bitstream/riufc/55888/3/2020_dis_artoliveira.pdf |
| bitstream.checksum.fl_str_mv |
8a4605be74aa9ea9d79846c1fba20a33 be274a18cb8508ec24ce528e73b96166 |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da Universidade Federal do Ceará (UFC) - Universidade Federal do Ceará (UFC) |
| repository.mail.fl_str_mv |
bu@ufc.br || repositorio@ufc.br |
| _version_ |
1847793404514140160 |